News

3 July 2019

New production line launched!

Polpharma B2B – your European API supplier

 

Continuous growth in the demand for Polpharma APIs, thanks to the highest quality and purity,
has led us to create new production line in highly acidic environment.

From now on we carry out reactions of Chlorosulfonic Acid, Phosphorus Trichloride, Thionyl chloride, in even more safe and efficient way.

 

“Our strategy for upcoming years assumes a significant growth in share of API segment within Polpharma Group.
Such investment is one of elements of further development. We continuously strive to improve our performance in meeting customer’s development and commercialization timelines,
on-time delivery of high-quality products confirmed by excellent audit history”, says Anita Jaranowska, B2B Sales Director.

 

New production line has been dedicated to our key API products of erectile dysfunction and musculo-skeletal system products.

Thanks to this investment we have increased production capacity, strengthening position of Polpharma as a worldwide API supplier.

Read more

CPhI MEA 2019
Polpharma B2B at CPhl Worldwide 2021
Drug safety cannot be guaranteed without access to active substances!